Medexus Pharmaceuticals (MDP) AGM 2026 summary

Opening remarks and agenda

• Chair welcomed shareholders, directors, and guests, outlined procedural details, and confirmed voting would be conducted online with questions accepted via the platform.

• Four formal business matters were set: presentation of financials, election of directors, reappointment of auditors, and approval of an amendment to the long-term incentive plan.

Financial performance review

• Consolidated financial statements for years ended March 31, 2026 and 2025, and the auditor's report, were presented and made available to shareholders.

Board and executive committee updates

• Seven directors were nominated and elected to serve until the next annual meeting or until successors are appointed.